Sandra Sánchez Barbosa

Dr. Sandra Sánchez Barbosa

UASLP, Ciudad Valles, San Luis Potosí, Mexico
+1
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2017 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
LZLuz Ángela Zárate-Neira
Luz Ángela Zárate-Neira
SBSandra Sánchez Barbosa
Sandra Sánchez Barbosa
APAbraham Pedroza-Torres
Abraham Pedroza-Torres
ARAlbany Reséndiz-Mora
Albany Reséndiz-Mora
CWCarlos Wong
Carlos Wong
CWCarlos Wong-Baeza
Carlos Wong-Baeza
Systemic lupus erythematosus (SLE) is characterized by deregulated activation of T and B cells, autoantibody production, and consequent formation of immune complexes. Liposomes with nonbilayer phospholipid arrangements (NPA), induced by chlorpromazine, procainamide, or manganese, provoke a disease resembling human lupus when administered to mice. These mice produce anti-NPA IgM and IgG antibodies and exhibit an increased number of TLR-expressing spleen cells and a modified gene expression associated with TICAM1-dependent TLR-4 signaling (including IFNA1 and IFNA2) and complement activation. Additionally, they showed a diminished gene expression related to apoptosis and NK cell activation. We hypothesized that such gene expression may be affected by miRNAs and so miRNA expression was studied. Twelve deregulated miRNAs were found. Six of them were common to the three lupus-like models. Their validation by qRT-PCR and TaqMan probes, including miR-342-3p, revealed that miR-155-5p and miR-200a-3p expression was statistically significant. Currently described functions for these miRNAs in autoimmune diseases such as SLE reveal their participation in inflammation, interferon production, germinal center responses, and antibody maturation. Taking into account these findings, we propose miR-155-5p and miR-200a-3p, together with the anti-NPA antibodies, as key players in the murine lupus-like models and possible biomarkers of the human SLE.

23 June 2022 in Membranes
Verified
Journal Article
Open access
PDF file
CLCarla Landa-Saldívar
Carla Landa-Saldívar
ARAlbany Resendiz-Mora
Albany Resendiz-Mora
SBSandra Sánchez Barbosa
Sandra Sánchez Barbosa
ASAnahi Sotelo-Rodriguez
Anahi Sotelo-Rodriguez
BBBarrera Aveleida Giovanna Berenice
Barrera Aveleida Giovanna Berenice
CWCarlos Wong-Baeza
Carlos Wong-Baeza
Liposomes are artificial models of cellular membranes that are used as delivery systems for genes, drugs and protein antigens. We have previously used them to study the antigenic properties of their phospholipids. Here, we used them to induce the production of IgG anti-non-bilayer phospholipid arrangements (NPAs) antibodies in mice; these antibodies cause cell lysis and trigger a lupus-like disease in mice. We studied the mechanisms that lead to the production of these antibodies, and provide evidence that NK1.1+, CD4+ T cells respond to NPA-bearing liposomes and deliver the help required for specific B cell activation and antibody class-switching to IgG. We found increased numbers of IL-4-producing NK1.1+, CD4+ T cells in the secondary lymphoid organs of mice administered with NPAs, and these cells also expressed CD40L, which is required for B cell activation. Additionally, we isolated and purified NK1.1+, CD4+ T cells from spleens and determined that they over-expressed 40 genes, which are key players in inflammatory processes and B cell stimulation and have TRAF6 and UNC39B1 as key nodes in their network. These results show that liposomes are membrane models that can be used to analyze the immunogenicity of lipids.

Verified
Journal Article
Open access
PDF file
Liseth Rubí Aldaba-MuruatoLiseth Rubí Aldaba-Muruato
Liseth Rubí Aldaba-Muruato
SBSandra Sánchez Barbosa
Sandra Sánchez Barbosa
VRVíctor Hugo Rodríguez-Purata
Víctor Hugo Rodríguez-Purata
GCGeorgina Cabrera-Cruz
Georgina Cabrera-Cruz
EREstefany Rosales-Domínguez
Estefany Rosales-Domínguez
JMJosé Roberto Macías-Pérez
José Roberto Macías-Pérez
Tert-butylhydroquinone (TBHQ) is a synthetic food antioxidant with biological activities, but little is known about its pharmacological benefits in liver disease. Therefore, this work aimed to evaluate TBHQ during acute liver damage induced by CCl4 (24 h) or BDL (48 h) in Wistar rats. It was found that pretreatment with TBHQ prevents 50% of mortality induced by a lethal dose of CCl4 (4 g/kg, i.p.), and 80% of BDL+TBHQ rats survived, while only 50% of the BDL group survived. Serum markers of liver damage and macroscopic and microscopic (H&E staining) observations suggest that TBHQ protects from both hepatocellular necrosis caused by the sublethal dose of CCl4 (1.6 g/kg, i.p.), as well as necrosis/ductal proliferation caused by BDL. Additionally, online databases identified 49 potential protein targets for TBHQ. Finally, a biological target candidate (Keap1) was evaluated in a proof-of-concept in silico molecular docking assay, resulting in an interaction energy of −5.5491 kcal/mol, which was higher than RA839 and lower than monoethyl fumarate (compounds known to bind to Keap1). These findings suggest that TBHQ increases the survival of animals subjected to CCl4 intoxication or BDL, presumably by reducing hepatocellular damage, probably due to the interaction of TBHQ with Keap1.